J.Jill (NYSE:JILL) Issues Earnings Results
by Renee Jackson · The Cerbat GemJ.Jill (NYSE:JILL – Get Free Report) issued its quarterly earnings results on Wednesday. The specialty retailer reported $0.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.58 by $0.18, FiscalAI reports. J.Jill had a return on equity of 40.48% and a net margin of 6.12%.The firm had revenue of $150.53 million during the quarter, compared to analyst estimates of $148.38 million. During the same period last year, the company posted $0.89 EPS.
J.Jill Trading Up 1.0%
J.Jill stock opened at $16.44 on Wednesday. J.Jill has a 12 month low of $13.32 and a 12 month high of $30.40. The company has a quick ratio of 0.64, a current ratio of 1.11 and a debt-to-equity ratio of 0.58. The stock has a market cap of $250.31 million, a P/E ratio of 6.88 and a beta of 0.90. The company’s fifty day simple moving average is $15.36 and its 200-day simple moving average is $15.85.
J.Jill Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 24th will be paid a dividend of $0.08 per share. The ex-dividend date of this dividend is Wednesday, December 24th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 1.9%. J.Jill’s dividend payout ratio (DPR) is 13.39%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of JILL. BNP Paribas Financial Markets raised its stake in shares of J.Jill by 83.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,483 shares of the specialty retailer’s stock worth $25,000 after purchasing an additional 673 shares in the last quarter. Rhumbline Advisers grew its stake in shares of J.Jill by 11.7% in the 1st quarter. Rhumbline Advisers now owns 7,908 shares of the specialty retailer’s stock valued at $154,000 after buying an additional 829 shares in the last quarter. Dynamic Technology Lab Private Ltd increased its holdings in J.Jill by 40.0% in the first quarter. Dynamic Technology Lab Private Ltd now owns 11,210 shares of the specialty retailer’s stock worth $219,000 after buying an additional 3,205 shares during the last quarter. Occudo Quantitative Strategies LP bought a new position in J.Jill during the third quarter valued at approximately $201,000. Finally, Bridgeway Capital Management LLC acquired a new stake in J.Jill in the third quarter valued at approximately $288,000. Hedge funds and other institutional investors own 40.71% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on JILL shares. Weiss Ratings restated a “sell (d+)” rating on shares of J.Jill in a report on Wednesday, October 8th. Cowen reiterated a “hold” rating on shares of J.Jill in a research report on Thursday, September 4th. Wall Street Zen upgraded shares of J.Jill from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Telsey Advisory Group reaffirmed a “market perform” rating and issued a $17.00 price objective on shares of J.Jill in a research note on Thursday, December 4th. Finally, Jefferies Financial Group cut their target price on shares of J.Jill from $22.00 to $20.00 and set a “buy” rating for the company in a research note on Wednesday, September 3rd. Two analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $20.00.
Get Our Latest Analysis on J.Jill
J.Jill Company Profile
J.Jill, Inc operates as an omnichannel retailer for women's apparel under the J.Jill brand in the United States. It offers apparel, footwear, and accessories, including scarves and jewelry. The company markets its products through retail stores, website, and catalogs. J.Jill, Inc was founded in 1959 and is headquartered in Quincy, Massachusetts.
Read More
- Five stocks we like better than J.Jill
- Top Biotech Stocks: Exploring Innovation Opportunities
- Insiders Are Selling These 3 Stocks—Here’s Why
- How to Evaluate a Stock Before Buying
- Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers
- 3 Warren Buffett Stocks to Buy Now
- 10X Gains? These 3 Robotics Stocks Could Explode by 2035